Medical Science News

RSS

Japan injects funds into fight against Bird Flu

Japan will support Cambodia, Indonesia, Laos and Viet Nam with $1.6 million in the fight against avian influenza, FAO announced today.

23 Mar 2004

70% of Americans not aware of their blood glucose (sugar) level

A new national survey conducted by the American Diabetes Association reveals that 7 out of 10 Americans are not aware of their blood glucose (sugar) level, critical information for determining the presence of diabetes or pre-diabetes. This awareness level is considered extremely low, especially as it relates to individuals' knowledge of blood pressure and cholesterol.

23 Mar 2004

New resorbable beta-tricalcium phosphate bone void filler

Therics, Inc., a subsidiary of Tredegar Corporation, announced that it has received FDA clearance to market a new resorbable beta-tricalcium phosphate bone void filler device used to treat osseous defects of the skeletal system.

22 Mar 2004

Enzyme Acetylcholinesterase (AChE), New Approach to Drug Design

French and American researchers have developed a unique approach to drug design where an important neuron-signaling enzyme called acetylcholinesterase (AChE) acts as a microscopic vessel filled with reactant chemicals, to create its own, tailored therapeutic agent.

22 Mar 2004

DNA repair enzymes to fight cancer

The body has a set of DNA repair enzymes that clean up damage to the genome, to reduce potential problems. Many commonly used cancer chemotherapies work by alkylating DNA. However, the DNA repair enzymes are just as capable of repairing this alkylation as if it were damage from any other source, and so they act to overcome the effects of the therapy, reducing its effectiveness.

22 Mar 2004

Scientists identify genetic changes during infection by tuberculosis

Researchers at the Center for Biomedical Inventions at UT Southwestern Medical Center at Dallas have identified the genetic changes that Mycobacterium tuberculosis, the bacterium that causes tuberculosis, undergoes during infection of a living host.

22 Mar 2004

AMT Obtains Orphan Drug Designation for Its LPL Gene Therapy Product

AMT today announced that its adeno-associated viral vector (AAV) expressing lipoprotein lipase (LPL) product has been designated as an orphan medicinal product for the treatment of LPL deficiency by the European Commission. This decision follows a positive recommendation by the European Agency for the Evaluation of Medicinal Products.

22 Mar 2004

Supercomputer to help the diagnosis of epilepsy, stroke, depression and other brain conditions

The University of Oregon, Electrical Geodesics, Inc. (EGI), and IBM have announced a new project that uses grid computing, Linux and IBM supercomputer technology to speed and improve the diagnosis of Epilepsy, stroke, depression and other brain conditions.

22 Mar 2004

Mouse antibodies neutralise SARS virus

The mouse immune system develops antibodies capable of single-handedly neutralizing the SARS virus, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) report in the April 1 issue of the Journal of Virology, now available online. NIAID is part of the National Institutes of Health (NIH).

22 Mar 2004

New Computer-Aided Approach Helps Doctors Tailor The Dosage of Abciximab

A computer-aided approach -- based on software-that-learns, promises to provide a new tool that helps doctors tailor the dosage of abciximab, a medicine frequently used before angioplasty to lessen the chance of heart attack.

22 Mar 2004